Showing 19,861 - 19,880 results of 101,805 for search '(( a teer decrease ) OR ( 5 ((non decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.68s Refine Results
  1. 19861

    Structure and Bonding Properties of the Complex (η<sup>5</sup>-Diphenylfulvene)Mn(CO)<sub>3</sub><sup>+</sup> by Martin A. O. Volland (3077121)

    Published 2000
    “…As a result of the bending of the exo methylene group the positive charge at the metal is increased and at C9 decreased.…”
  2. 19862

    Reduced Long-Term Relative Survival in Females and Younger Adults Undergoing Cardiac Surgery: A Prospective Cohort Study by Tone Bull Enger (668126)

    Published 2016
    “…The observed 30-day, 1-, 3- and 5-year mortality rates were 2.2%, 4.4%, 8.2% and 13.8%, respectively, and remained constant throughout the study period. …”
  3. 19863

    An overview of study characteristics. by Akhmedkhan Dubayev (17879559)

    Published 2024
    “…</p><p>Results</p><p>Twenty-five studies were included (5 randomized controlled trials, 20 non-randomized controlled trials). …”
  4. 19864

    Summary of NOS bias assessments. by Akhmedkhan Dubayev (17879559)

    Published 2024
    “…</p><p>Results</p><p>Twenty-five studies were included (5 randomized controlled trials, 20 non-randomized controlled trials). …”
  5. 19865

    QST characteristics. by Akhmedkhan Dubayev (17879559)

    Published 2024
    “…</p><p>Results</p><p>Twenty-five studies were included (5 randomized controlled trials, 20 non-randomized controlled trials). …”
  6. 19866

    Metallization of a Hypervalent Radical Dimer: Molecular and Band Perspectives by John S. Tse (1321242)

    Published 2010
    “…Variable pressure and temperature conductivity measurements on the bisthiaselenazolyl radical dimer [<b>1a</b>]<sub>2</sub> have established the presence of a weakly metallic state over the pressure range 5−9 GPa. …”
  7. 19867

    Metallization of a Hypervalent Radical Dimer: Molecular and Band Perspectives by John S. Tse (1321242)

    Published 2010
    “…Variable pressure and temperature conductivity measurements on the bisthiaselenazolyl radical dimer [<b>1a</b>]<sub>2</sub> have established the presence of a weakly metallic state over the pressure range 5−9 GPa. …”
  8. 19868

    Metallization of a Hypervalent Radical Dimer: Molecular and Band Perspectives by John S. Tse (1321242)

    Published 2010
    “…Variable pressure and temperature conductivity measurements on the bisthiaselenazolyl radical dimer [<b>1a</b>]<sub>2</sub> have established the presence of a weakly metallic state over the pressure range 5−9 GPa. …”
  9. 19869

    Metallization of a Hypervalent Radical Dimer: Molecular and Band Perspectives by John S. Tse (1321242)

    Published 2010
    “…Variable pressure and temperature conductivity measurements on the bisthiaselenazolyl radical dimer [<b>1a</b>]<sub>2</sub> have established the presence of a weakly metallic state over the pressure range 5−9 GPa. …”
  10. 19870

    Metallization of a Hypervalent Radical Dimer: Molecular and Band Perspectives by John S. Tse (1321242)

    Published 2010
    “…Variable pressure and temperature conductivity measurements on the bisthiaselenazolyl radical dimer [<b>1a</b>]<sub>2</sub> have established the presence of a weakly metallic state over the pressure range 5−9 GPa. …”
  11. 19871
  12. 19872

    Table_2_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.docx by Xiao-yang Gong (13103400)

    Published 2022
    “…</p>Results<p>To the best to our knowledge, we present for the first time an overview of the genomic mutation spectrum of early-stage laryngeal cancers. A total of 469 genomic alterations were detected in 211 distinct cancer-relevant genes, and the genes found to be mutated in more than five patients (>10%) included tumor protein p53 (TP53, 78.5%), FAT atypical cadherin 1 (FAT1, 26%), LDL receptor related protein 1B (LRP1B, 19%), cyclin dependent kinase inhibitor 2A (CDKN2A, 17%), tet methylcytosine dioxygenase 2 (TET2, 17%), notch receptor 1 (NOTCH1, 12%) and neuregulin 1 (NRG1, 12%). …”
  13. 19873

    Image_2_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.tif by Xiao-yang Gong (13103400)

    Published 2022
    “…</p>Results<p>To the best to our knowledge, we present for the first time an overview of the genomic mutation spectrum of early-stage laryngeal cancers. A total of 469 genomic alterations were detected in 211 distinct cancer-relevant genes, and the genes found to be mutated in more than five patients (>10%) included tumor protein p53 (TP53, 78.5%), FAT atypical cadherin 1 (FAT1, 26%), LDL receptor related protein 1B (LRP1B, 19%), cyclin dependent kinase inhibitor 2A (CDKN2A, 17%), tet methylcytosine dioxygenase 2 (TET2, 17%), notch receptor 1 (NOTCH1, 12%) and neuregulin 1 (NRG1, 12%). …”
  14. 19874

    Table_4_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.docx by Xiao-yang Gong (13103400)

    Published 2022
    “…</p>Results<p>To the best to our knowledge, we present for the first time an overview of the genomic mutation spectrum of early-stage laryngeal cancers. A total of 469 genomic alterations were detected in 211 distinct cancer-relevant genes, and the genes found to be mutated in more than five patients (>10%) included tumor protein p53 (TP53, 78.5%), FAT atypical cadherin 1 (FAT1, 26%), LDL receptor related protein 1B (LRP1B, 19%), cyclin dependent kinase inhibitor 2A (CDKN2A, 17%), tet methylcytosine dioxygenase 2 (TET2, 17%), notch receptor 1 (NOTCH1, 12%) and neuregulin 1 (NRG1, 12%). …”
  15. 19875

    Table_1_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.docx by Xiao-yang Gong (13103400)

    Published 2022
    “…</p>Results<p>To the best to our knowledge, we present for the first time an overview of the genomic mutation spectrum of early-stage laryngeal cancers. A total of 469 genomic alterations were detected in 211 distinct cancer-relevant genes, and the genes found to be mutated in more than five patients (>10%) included tumor protein p53 (TP53, 78.5%), FAT atypical cadherin 1 (FAT1, 26%), LDL receptor related protein 1B (LRP1B, 19%), cyclin dependent kinase inhibitor 2A (CDKN2A, 17%), tet methylcytosine dioxygenase 2 (TET2, 17%), notch receptor 1 (NOTCH1, 12%) and neuregulin 1 (NRG1, 12%). …”
  16. 19876

    Image_1_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.tif by Xiao-yang Gong (13103400)

    Published 2022
    “…</p>Results<p>To the best to our knowledge, we present for the first time an overview of the genomic mutation spectrum of early-stage laryngeal cancers. A total of 469 genomic alterations were detected in 211 distinct cancer-relevant genes, and the genes found to be mutated in more than five patients (>10%) included tumor protein p53 (TP53, 78.5%), FAT atypical cadherin 1 (FAT1, 26%), LDL receptor related protein 1B (LRP1B, 19%), cyclin dependent kinase inhibitor 2A (CDKN2A, 17%), tet methylcytosine dioxygenase 2 (TET2, 17%), notch receptor 1 (NOTCH1, 12%) and neuregulin 1 (NRG1, 12%). …”
  17. 19877

    Table_3_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.docx by Xiao-yang Gong (13103400)

    Published 2022
    “…</p>Results<p>To the best to our knowledge, we present for the first time an overview of the genomic mutation spectrum of early-stage laryngeal cancers. A total of 469 genomic alterations were detected in 211 distinct cancer-relevant genes, and the genes found to be mutated in more than five patients (>10%) included tumor protein p53 (TP53, 78.5%), FAT atypical cadherin 1 (FAT1, 26%), LDL receptor related protein 1B (LRP1B, 19%), cyclin dependent kinase inhibitor 2A (CDKN2A, 17%), tet methylcytosine dioxygenase 2 (TET2, 17%), notch receptor 1 (NOTCH1, 12%) and neuregulin 1 (NRG1, 12%). …”
  18. 19878

    Graphic representation of the relation between the mean values of alveolar volume, calculated by the quintile method, and those of the corresponding DLCO, in healthy individuals (p... by Renato Prediletto (86307)

    Published 2011
    “…</p><p></p> The alveolar volume does not show any remarkable change when related to the expired volume in healthy individuals (only 300 ml), at variance with those of COPD patients. In addition, DLCO decreases by 1.5 mmol/min/mmHg with respect to the slight changes of the alveolar volume in healthy individuals, whereas it increases by less than 1 mmol/min/mmHg for a total increase of 2.5 litres of alveolar volume in COPD patients from TLC to RV.…”
  19. 19879
  20. 19880

    CRISPRi knockdown of Lon protease to increase half-life. by Nicholas A. Rossi (3622865)

    Published 2018
    “…Negative and positive values indicate relative changes in concentration compared to the mean. <b>(B)</b> Analytical solutions for the variability of a protein as a function of differing half-lives. …”